This is one of the most important posts we've written, and we want to be straightforward about why.
Methylene Blue is a compound with real, documented interactions with certain medications and health conditions. These aren't theoretical concerns or excessive caution — they're well-established in clinical literature and worth understanding clearly before anyone decides whether it's appropriate for them.
We're writing this post because we think transparency here is part of what responsible practice in this category looks like. We'd rather lose a sale than have someone with a contraindicated medication or health condition encounter an avoidable problem.
This is not medical advice. It's a plain-English summary of what is known about Methylene Blue safety considerations, intended to help you have a more informed conversation with your healthcare provider if you're considering it.
The Most Serious Interaction: Serotonergic Medications
The most clinically significant interaction associated with Methylene Blue is with medications and substances that affect serotonin levels — a condition known as serotonin syndrome.
Methylene Blue inhibits monoamine oxidase (MAO), an enzyme involved in breaking down serotonin and other neurotransmitters. When combined with medications that also increase serotonin — by preventing its breakdown, blocking its reuptake, or stimulating its release — the result can be dangerously elevated serotonin levels.
Serotonin syndrome can range from mild (agitation, restlessness, rapid heart rate) to severe (high fever, seizures, irregular heartbeat). In serious cases it requires medical treatment.
Medications with known interaction risk include:
- SSRIs (Selective Serotonin Reuptake Inhibitors): fluoxetine (Prozac), sertraline (Zoloft), escitalopram (Lexapro), paroxetine, citalopram, and others — among the most commonly prescribed antidepressants in Australia
- SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors): venlafaxine (Effexor), duloxetine (Cymbalta), desvenlafaxine
- MAOIs (Monoamine Oxidase Inhibitors): phenelzine, tranylcypromine, moclobemide — serious interaction risk
- Tricyclic antidepressants: amitriptyline, nortriptyline, clomipramine
- Tramadol: a commonly prescribed painkiller with serotonergic activity
- Certain migraine medications (triptans): sumatriptan, zolmitriptan, others
- St John's Wort: a commonly used herbal supplement with serotonergic activity
- Lithium: used in bipolar disorder management
This list is not exhaustive. If you are taking any medication for depression, anxiety, pain management, or mood — please consult your doctor or pharmacist before considering Methylene Blue.
Illicit substances: MDMA, amphetamines, and cocaine also have serotonergic activity and carry interaction risk. This is not a moral comment — it's a pharmacological one.
G6PD Deficiency: A Condition That Contraindicates Use
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is an inherited condition affecting red blood cells. People with this condition lack a critical enzyme involved in protecting red blood cells from oxidative damage.
Methylene Blue should not be used by people with G6PD deficiency. In this population, it can cause haemolytic anaemia — a condition where red blood cells are destroyed faster than they can be produced, leading to fatigue, shortness of breath, jaundice, and in serious cases, more significant complications.
G6PD deficiency is more prevalent in certain populations, including people of African, Mediterranean, Middle Eastern, and Asian descent. Many people with the condition don't know they have it because symptoms may not appear until triggered by specific substances or infections.
If you're unsure whether you have G6PD deficiency, your GP can arrange a simple blood test.
Pregnancy and Breastfeeding
Methylene Blue is not appropriate for use during pregnancy.
In clinical medicine, Methylene Blue injection has been associated with fetal intestinal abnormalities when administered during pregnancy. This is sufficiently documented that it is contraindicated in pregnant patients in clinical settings.
The evidence base for oral Methylene Blue in pregnancy is less extensive, but the precautionary principle applies firmly: avoid use during pregnancy.
Similarly, there is no data on whether Methylene Blue passes into breast milk. In the absence of safety data, the cautious approach is to avoid use while breastfeeding.
Kidney Function
Methylene Blue is processed and excreted through the kidneys. People with impaired kidney function may not clear the compound as efficiently, which can affect how it behaves in the body.
If you have known kidney disease or reduced kidney function, consult your healthcare provider before considering Methylene Blue.
High Doses: A Paradox Worth Understanding
There is a well-documented paradox with Methylene Blue: at very high doses, it can actually cause the same condition it is used clinically to treat at lower doses — methemoglobinemia (abnormal haemoglobin that can't carry oxygen properly).
At the low concentrations typical of 1% solution use, this is not a concern for healthy individuals. But it illustrates an important principle: the dose matters significantly with this compound, and more is not better. Larger amounts do not produce proportionally greater effects — the relationship is more complex than that.
Other Medications to Be Aware Of
Beyond serotonergic drugs, Methylene Blue has documented interactions with several other medication classes:
- Adrenaline (epinephrine) and related compounds: Used in emergency settings; interaction risk noted
- Muscle relaxants: Some interactions have been documented
- Certain anaesthetic agents: This is why anaesthesiologists need to know if patients have recently used Methylene Blue — relevant if you are having any procedure under anaesthesia
If you are having surgery or a medical procedure, make sure your anaesthetist knows if you have used Methylene Blue recently.
What We Recommend
We're not in a position to give you medical advice, and we're not trying to. What we will say clearly is this:
If you are on any regular medication — particularly antidepressants, anti-anxiety medications, pain medications, or any supplement that affects mood or energy — please speak with your GP or pharmacist before considering Methylene Blue.
This is not a standard disclaimer inserted to tick a box. It's genuinely important information.
The interaction risks with serotonergic medications are real and can be serious. For many people — those with no contraindicated medications, no G6PD deficiency, and not pregnant — these risks don't apply. But knowing your situation matters.
Your GP can review your medication list and give you a clear picture. That's a short conversation worth having.
Why We're This Direct About It
Because we think brands in this space have a responsibility to be honest about what is and isn't known — not just about what's interesting or appealing.
We test every batch of our product independently. We name our testing laboratory. And we tell you clearly what the known risks are, even when that's uncomfortable.
That's what trust looks like from our end.
If you have questions or want to talk through any of this, reach out. We're happy to help.
— The Waves of Wellbeing Team
This product is not registered with the TGA and is not intended to diagnose, treat, cure, or prevent any disease. This post is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before using any supplement or wellness product, particularly if you take prescription medications or have existing health conditions.